persantin pl perlongets
boehringer ingelheim (nz) limited - dipyridamole 150mg; - modified release capsule - 150 mg - active: dipyridamole 150mg excipient: acacia acetone dimeticone ethanol gelatin hypromellose hypromellose phthalate isopropyl alcohol methacrylic acid copolymer povidone purified talc purified water stearic acid tartaric acid triacetin
persantin sr dipyridamole 200mg capsule bottle
boehringer ingelheim pty ltd - dipyridamole -
persantin dipyridamole 10mg/2ml injection ampoule
clinect pty ltd - dipyridamole, quantity: 5 mg/ml - injection, solution - excipient ingredients: macrogol 600; tartaric acid; water for injections; hydrochloric acid - indications as at 29 august 2000: persantin ampoules are indicated as an alternative to exercise in myocardial imaging.
persantine- dipyridamole tablet, coated
boehringer ingelheim pharmaceuticals, inc. - dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - dipyridamole 25 mg - persantine tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement. hypersensitivity to dipyridamole and any of the other components.
persantin retard
ltt pharma limited - dipyridamole - capsules modified release - 200 milligram
persantin sr
boehringer ingelheim pty ltd - dipyridamole -
persantin retard 200 mg modified release capsules, hard
boehringer ingelheim limited - dipyridamole - capsules modified release - 200 milligram(s) - platelet aggregation inhibitors excl. heparin; dipyridamole
persantin retard 200 milligram capsules modified release
ltt pharma limited - dipyridamole - capsules modified release - 200 milligram
persantin 100mg tablets
boehringer ingelheim ltd - dipyridamole - oral tablet - 100mg
persantin regard
imed healthcare ltd. - dipyridamole - capsules modified release - 200 milligram